Archimedes Pharma: A Thriving Speciality Pharma




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Archimedes Pharma: A Thriving Speciality Pharma
Released on: April 01, 2008. © PharmaVentures Ltd
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    In this new interview, Fintan Walton talks to Richard de Souza, CEO of Archimedes Pharma.
  • Summary
  • Participants
  • Company
In this new interview, Fintan Walton talks to Richard de Souza, CEO of Archimedes Pharma. Richard describes how Archimedes' strategy has evolved over the 18 months since his last appearance on PharmaTelevision. He discusses the strategic acquisitions the company has undertaken to establish itself, and summarises the company's presence within the major European markets. An interesting conversation develops about the challenges facing speciality pharma in Europe, followed by Richard's outline of Archimedes' current plans for commercialising their products in the US. The two conclude the interview with a discussion of the de-risking of Archimedes' development strategy, how this was applied to its lead product, NasalFentĀ®, and the company's plans for the coming 12 months.
Richard de Souza is CEO of Archimedes Pharma, a speciality pharmaceutical company founded in December 2004 and based in Reading, UK. Before co-founding Archimedes with two other former Shire Pharmaceuticals Group executives, he served for 4 years as Director, International at Shire, where he was responsible for significant growth of the Pharma Business in Europe and the Asia-Pacific region, and of the Diagnostics and Biologicals Businesses globally. Before that, from 1999, Richard was at Warner-Lambert as President, Europe and International; he left Warner-Lambert after its merger with Pfizer in 2000, to go to Shire. Richard is a pharmacist who started his career at SmithKline Beecham in manufacturing, and then moved on through business development and marketing roles into general management; in 1995 he was appointed Chairman, Europe Pharma at SmithKline Beecham.
Archimedes Pharma Ltd
Archimedes is a European specialty pharmaceutical company with an established commercial organisation in the UK, France, Germany, Ireland and Spain and a portfolio of products marketed to specialist prescribers. Archimedes is growing its commercial presence through the acquisition of pharmaceutical companies and brands in Europe, and through partnering with companies to drive sales of their innovative products. In parallel, Archimedes is developing a robust pipeline of novel near and longer-term products to support its commercial organisation.